WallStreetZenWallStreetZen

NASDAQ: BGNE
Beigene Ltd Earnings & Revenue

BGNE past revenue growth

How has BGNE's revenue growth performed historically?
Company
77.42%
Industry
88.96%
Market
19.65%
BGNE's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BGNE's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BGNE's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BGNE earnings and revenue history

Current Revenue
$2.8B
Current Earnings
-$784.4M
Current Profit Margin
-28.4%

BGNE Return on Equity

Current Company
-21.7%
Current Industry
16.8%
Current Market
28.2%
BGNE's Return on Equity (-21.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BGNE announces earnings.

BGNE Return on Assets

Current Company
-13.8%
Current Industry
3.2%
BGNE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BGNE Return on Capital Employed

Current Company
-21.3%
Current Industry
-42.4%
BGNE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BGNE vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BGNE$2.76B-$713.52M-$784.43M+62.54%N/A
BMRN$2.47B$359.85M$205.46M+10.23%+14.24%
RPRX$2.24B$983.33M$798.86M+4.46%+57.82%
SRPT$1.40B$91.13M$16.90M+34.11%N/A
UTHR$2.50B$1.49B$1.05B+9.30%+16.74%

BGNE earnings dates

Next earnings date
Jul 31, 2024

Beigene Earnings & Revenue FAQ

What were BGNE's earnings last quarter?

On Invalid Date, Beigene (NASDAQ: BGNE) reported Q1 2024 earnings per share (EPS) of -$0.19, up 26.92% year over year. Total Beigene earnings for the quarter were -$251.15 million. In the same quarter last year, Beigene's earnings per share (EPS) was -$0.26.

If you're new to stock investing, here's how to buy Beigene stock.

What was BGNE's earnings growth in the past year?

As of Q3 2024, Beigene's earnings has grown year over year. Beigene's earnings in the past year totalled -$784.43 million.

What is BGNE's earnings date?

Beigene's earnings date is Invalid Date. Add BGNE to your watchlist to be reminded of BGNE's next earnings announcement.

What was BGNE's revenue last quarter?

On Invalid Date, Beigene (NASDAQ: BGNE) reported Q1 2024 revenue of $751.65 million up 67.85% year over year. In the same quarter last year, Beigene's revenue was $447.80 million.

What was BGNE's revenue growth in the past year?

As of Q3 2024, Beigene's revenue has grown 77.42% year over year. This is 11.54 percentage points lower than the US Biotechnology industry revenue growth rate of 88.96%. Beigene's revenue in the past year totalled $2.76 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.